Global Anticoagulant Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2022 to 2028

Description

List of Tables

Value Market Research deeply researched the Global Anticoagulant Market to foresee a significant growth in the industry over the upcoming years. The global anticoagulant market report provides a complete industry analysis, market size, market share, growth trends, and forecasts for 2023 to 2028. The report starts with a detailed market introduction and an executive summary that highlights the report's key growth numbers. The subsequent chapters discuss the value chain of the market, Porter's Five Forces Model, and market attractiveness analysis. An exclusive chapter on COVID-19 impact analysis has been added to understand how the market has responded to the pandemic.

The market dynamics section of the report elaborates the current market drivers, restraints along with the challenges/risks and upcoming opportunities. This section can be of high interest for any company's strategists and new product development department. The global anticoagulant market study segments the market and provides the market size in terms of revenue and/ or sales. This data is bifurcated by region and later by countries. The data is collected through detailed primary interviews and industry experts across the world. The detailed methodology can be seen in our sample reports. These market estimates are also influenced by the latest social, political and economic changes along with the current market dynamics that are affecting this anticoagulant market.

The next sections of the anticoagulant market report studies the market competitiveness and profiles some key market players/manufacturers. These sections are knowledgeable for understanding the competitor's product-line, their financials, recent developments and the top market share owners in the industry.

Countries Covered in the report are as below:

North America: United States, Canada, and Mexico

Europe: United Kingdom, Germany, France, Italy, Russia, Spain & Rest of Europe

Asia-Pacific: China, India, Japan, South Korea, Australia & Rest of APAC

Latin America: Brazil, Argentina, Peru, Chile & Rest of Latin America

Middle East and Africa: Saudi Arabia, UAE, Israel, South Africa

Market Segmentation in the report is as below:

By Drug Class

NOACs

Heparin & LMWH

Vitamin K Antagonist

Others

By Route Of Administration

Injectable Anticoagulant

Oral Anticoagulant

By Application

Stroke

Atrial Fibrillation

Pulmonary Embolism (PE)

Deep Vein Thrombosis (DVT)

Others

Product Code: VMR11211613

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Anticoagulant Market
2.2. Global Anticoagulant Market Snapshot

3 . ANTICOAGULANT - INDUSTRY ANALYSIS

3.1. Introduction
3.2. Market Drivers of Anticoagulant Market
3.3. Market Restraints of Anticoagulant Market
3.4. Opportunities of Anticoagulant Market
3.5. Trends of Anticoagulant Market
3.6. Porter's Five Force Analysis of Anticoagulant Market
3.7. Anticoagulant Market Attractiveness Analysis
- 3.7.1 Market Attractive Analysis by Drug Class
- 3.7.2 Market Attractive Analysis by Route Of Administration
- 3.7.3 Market Attractive Analysis by Application
- 3.7.4 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS

4.1. Anticoagulant Value Chain Analysis
4.2. Anticoagulant Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Anticoagulant Raw Material Manufactures List
- 4.2.3. Price Trend of Anticoagulant Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL ANTICOAGULANT MARKET ANALYSIS BY DRUG CLASS

5.1 Overview by Drug Class
5.2 Global Anticoagulant Market Analysis by Drug Class
5.3 Market Analysis of NOACs by Regions
5.4 Market Analysis of Heparin & LMWH by Regions
5.5 Market Analysis of Vitamin K Antagonist by Regions
5.6 Market Analysis of Others by Regions

6 . GLOBAL ANTICOAGULANT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

6.1 Overview by Route Of Administration
6.2 Global Anticoagulant Market Analysis by Route Of Administration
6.3 Market Analysis of Injectable Anticoagulant by Regions
6.4 Market Analysis of Oral Anticoagulant by Regions

7 . GLOBAL ANTICOAGULANT MARKET ANALYSIS BY APPLICATION

7.1 Overview by Application
7.2 Global Anticoagulant Market Analysis by Application
7.3 Market Analysis of Stroke by Regions
7.4 Market Analysis of Atrial Fibrillation by Regions
7.5 Market Analysis of Pulmonary Embolism (PE) by Regions
7.6 Market Analysis of Deep Vein Thrombosis (DVT) by Regions
7.7 Market Analysis of Others by Regions

8 . GLOBAL ANTICOAGULANT MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America
- 8.3.1. Overview
- 8.3.2. North America Anticoagulant Market Estimate by Country
- 8.3.3. United State
- 8.3.4. Rest of North America
8.4. Europe
- 8.4.1. Overview
- 8.4.2. Europe Anticoagulant Market Estimate by Market Segment
- 8.4.3. Europe Anticoagulant Market Estimate by Country
- 8.4.4. United Kingdom
- 8.4.5. France
- 8.4.6. Germany
- 8.4.7 Rest of Europe
8.5. Asia Pacific
- 8.5.1. Overview
- 8.5.2. Asia Pacific Anticoagulant Market Estimate by Market Segment
- 8.5.3. Asia Pacific Anticoagulant Market Estimate by Country
- 8.5.4. China
- 8.5.5. Japan
- 8.5.6. India
- 8.5.7. Rest of Asia Pacific
8.6. Latin America
- 8.6.1. Overview
- 8.6.2. Latin America Anticoagulant Market Estimate by Market Segment
- 8.6.3. Latin America Anticoagulant Market Estimate by Country
- 8.6.4. Brazil
- 8.6.5. Rest of Latin America
8.7. Middle East & Africa
- 8.7.1. Overview
- 8.7.2. Middle East & Africa Anticoagulant Market Estimate by Market Segment
- 8.7.3. Middle East & Africa Anticoagulant Market Estimate by Country
- 8.7.4. Middle East
- 8.7.5. Africa

9 . COMPETITIVE LANDSCAPE OF THE ANTICOAGULANT COMPANIES

9.1. Anticoagulant Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF ANTICOAGULANT INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Bayer AG
- 10.3.1. Company Overview
- 10.3.2. Financials
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Aspen Holdings
- 10.4.1. Company Overview
- 10.4.2. Financials
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Boehringer Ingelheim GmbH
- 10.5.1. Company Overview
- 10.5.2. Financials
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Daiichi Sankyo Company, Limited
- 10.6.1. Company Overview
- 10.6.2. Financials
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. Bristol-Myers Squibb Company
- 10.7.1. Company Overview
- 10.7.2. Financials
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. GlaxoSmithKline
- 10.8.1. Company Overview
- 10.8.2. Financials
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Pfizer, Inc.
- 10.9.1. Company Overview
- 10.9.2. Financials
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Sanofi S.A.
- 10.10.1. Company Overview
- 10.10.2. Financials
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. Johnson & Johnson
- 10.11.1. Company Overview
- 10.11.2. Financials
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. Portola Pharmaceuticals, Inc.
- 10.12.1. Company Overview
- 10.12.2. Financials
- 10.12.3. Products
- 10.12.4. Recent Developments

Note - In company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies